Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

8 results
Display

Restoration of lymphokine-activated killer cell response with indomethacin in tumor bearing mice

Yun YS, Jung IS, Yun JS

  • KMID: 2082992
  • Korean J Immunol.
  • 1993 Nov;15(2):255-261.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of interferon-alpha and -gamma on lymphokine-activated killer cell activity induced by interleukin-2

Choi Y, Choi YK, Kim JM, Chung YH, Kim KH, Han WS

  • KMID: 1687990
  • J Korean Soc Microbiol.
  • 1992 Aug;27(4):371-380.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Change of NK Cell and LAK Cell Activity of Cancer Patients in Postchemotherapy Period

Chung CS, Choeh K, Choi YM

  • KMID: 1682857
  • J Korean Pediatr Soc.
  • 1989 Jul;32(7):933-942.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Lymphokine-activated killer(LAK) Cell Activity and Phenotypic Characterization in Peripheral Lymphocytes of Patients with Cervical Cancer

Kim SR, Kim KT, Cho SH, Hwang YY, Lee JA, Moon H, Kim JM, Cho YJ

  • KMID: 2083705
  • Korean J Gynecol Oncol Colposc.
  • 1992 Mar;3(1):10-23.
In adoptive immunotherapy of cancer using lymphokine-activated killer(LAK) cells indueed from patients own peripheral blood, the efficient cytotoxicity of LAK cells is a principal requirement. Peripheral blood lyrnphocytes were obtained...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Treatment of hepatoma with hepatic artery infusion of LAK cell and intravenous interleukin-2

Lee KS, Kim BR, Choi SH

  • KMID: 1685441
  • Korean J Gastroenterol.
  • 1992 Aug;24(4):798-808.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of target cell nitric oxide synthesis on the sensitivity to lymphokine-activated killer cell cytotoxicity

Park SI, Park JH, Lee CK, Kim SC, Choi BG, Kwak JY, Yim CY

BACKGROUND: Nitric oxide (NO), a cytotoxic molecule is produced in various tissues including tumor cells during interleukin-2 (IL-2) therapy . Lymphokine-activated killer (LAK) cells are induced during IL-2 therapy, and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The effect of interleukin 2 on the induction Of Nk 1.1 expression in CD8+ and CD4-CD8-T Cell

Cho YJ, Chang YH

  • KMID: 2286159
  • J Asthma Allergy Clin Immunol.
  • 1998 Jun;18(2):290-298.
BACKGROUND: Murine IL-2-induced lymphokine-activated killers can be divided into two mutually exclusive subset:NK1.1'CD8 and NK1.1 CD8+. However, there is a strong evidence that NK cell may belong to T cell lineage. Recently...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of nitric oxide (NO) synthesis inhibition on antitumor responses during interleukin-2 (IL-2) treatment of mice

Yim CY, Lee CW, Choi SM, Park SS, Lee SJ, Kim JH, Song JS, Yoo WH, Kwak JY, Sohn MH

  • KMID: 1051549
  • Korean J Intern Med.
  • 1996 Jun;11(2):93-100.
OBJECTIVES: To evaluate if L-arginine: NO pathway is activated in tumor tissues during IL-2 therapy and to evaluate whether IL-2 induced NO synthesis represents an antitumor effector mechanism or an...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr